JYSB2300119 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | | | | view |
JYSB2300117 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | | | | view |
JYSB2300118 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | | | | view |
CXSS2300027 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2023-04-27 | | QILU Pharmaceutical Co Ltd | | | view |
JYSZ2200056 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | | | | view |
JYSZ2200058 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | | | | view |
JYSZ2200057 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | | | | view |
CXSS2200015 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2022-02-17 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
CYSB2200023 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2022-01-21 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
CXSS2200005 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2022-01-14 | | Hisun Biopharmaceutical Co Ltd | | | view |
CYSB2101225 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | | | | view |
CYSB2101224 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | | | | view |
CYSB2101215 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
CYSB2101216 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
CXSS2101019 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2021-08-05 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
JYSB2101009 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.1) | Supplementary Application | 2021-04-12 | | | | | view |
CYSB2000307 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-25 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2021-02-05 | view |
CYSB2000306 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-25 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2022-01-27 | view |
CXSB2000101 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-24 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-11-23 | view |
CYSB2000229 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-10-17 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-10-16 | view |